Home > Healthcare > Medical Devices > Therapeutic Devices > Extracorporeal Membrane Oxygenation Market
Extracorporeal Membrane Oxygenation Market size was valued at more than USD 490 million in 2022 and is poised to register over 3.4% CAGR between 2023 and 2032.
Extracorporeal membrane oxygenation is also known as extracorporeal life support. It is a life-supporting system that provides respiratory and cardiac support to the patients suffering from severe respiratory failure. Increasing awareness among patients regarding the importance of cardiopulmonary assistance for severe cardiac and respiratory conditions, thereby will accelerate the adoption rate of ECMO therapy.
Growing adoption of unhealthy habits such as excessive smoking, tobacco consumption, and alcohol consumption contribute to the existing burden of lung diseases. Moreover, a large patient population base is suffering from lung and heart diseases in highly populated countries such as China and India. This is expected to offer numerous industry growth opportunities in these countries.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Extracorporeal Membrane Oxygenation Market Size in 2022: | USD 490 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 3% |
2032 Value Projection: | USD 639 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 145 |
Tables, Charts & Figures: | 196 |
Segments covered: | Modality, Application, Patient Population, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|